Background: Home blood pressure monitoring has many benefits, even more so, in populations prone to high blood pressure, such as persons with diabetes.
Objective: The purpose of this research was to validate the QardioArm mobile device in a sample of individuals with noninsulin-dependent type 2 diabetes in accordance with the guidelines of the second International Protocol of the European Society of Hypertension.
Methods: The sample consisted of 33 patients with type 2 diabetes. To evaluate the validity of QardioArm by comparing its data with that obtained with a digital sphygmomanometer (Omron M3 Intellisense), two nurses collected diastolic blood pressure, systolic blood pressure, and heart rate with both devices.
Results: The analysis indicated that the test device QardioArm met all the validation requirements using a sample population with type 2 diabetes.
Conclusions: This paper reports the first validation of QardioArm in a population of individuals with noninsulin-dependent type 2 diabetes. QardioArm for home monitoring of blood pressure and heart rate met the requirements of the second International Protocol of the European Society of Hypertension.
Keywords: blood pressure; hypertension; mobile applications; software validation; type 2 diabetes.
©Victoria Mazoteras-Pardo, Ricardo Becerro-De-Bengoa-Vallejo, Marta Elena Losa-Iglesias, Eva María Martínez-Jiménez, César Calvo-Lobo, Carlos Romero-Morales, Daniel López-López, Patricia Palomo-López. Originally published in the Journal of Medical Internet Research (http://www.jmir.org), 24.07.2020.